Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• Patients with pathologically confirmed pancreatic cancer (primary)
• Patients who underwent Radical resection of pancreatic cancer（Pancreaticoduodenectomy or Distal pancreatectomy）
• The postoperative survival time was at least 6 weeks
Locations
Other Locations
China
Hepatopancreatobiliary Surgery Institute of Gansu Province
RECRUITING
Lanzhou
Contact Information
Primary
Wenbo Meng, M.D. Ph. D.
mengwb@163.com
13919177177
Backup
Zhengping An, M.D.
anzhp2023@lzu.edu.cn
18298415512
Time Frame
Start Date: 2025-07-29
Estimated Completion Date: 2026-12-29
Participants
Target number of participants: 168
Treatments
High serum uric acid
The increase of after serum uric acid operation compared with that before operation is≥10% Normal levels serum uric acid are typically 178 to 360 μm (3 to 6.8 mg/dl).
Low serum uric acid
The increase of after serum uric acid operation compared with that before operation \< 10% Normal serum uric acid levels are typically 178 to 360 μm (3 to 6.8 mg/dl).
Related Therapeutic Areas
Sponsors
Leads: Hepatopancreatobiliary Surgery Institute of Gansu Province